Lease Agreement (August 14th, 2015)
THIS LEASE ("Lease") is made on March 29, 2012 between The Bubble Real Estate Company, LLC. a California limited liability company, (hereinafter referred to as "Lessor") and Capricor, Inc., a Delaware Incorporation located at 8700 Beverly Blvd, Davis Building Rm. # 1099 Los Angeles, CA 90048 (hereinafter referred to as "Lessee").
Contract (March 6th, 2015)
Stock Awards, Warrants and Options [Abstract] Statement [Table] Equity Components [Axis] Equity Component [Domain] Statement [Line Items] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] STOCK AWARDS, WARRANTS AND OPTIONS Risks and Uncertainties [Abstract] Legal Entity [Axis] Entity [Domain] Concentration Risk Disclosure [Text Block] CONCENTRATIONS Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] COMMITMENTS AND CONTINGENCIES License Agreements [Abstract] LICENSE AGREEMENTS [Text Block] LICENSE AGREEMENTS The entire disclosure relating to licensing agreements entered into for acquiring intellectual property rights, for the grant of an exclusive, world-wide, roya
Contract (May 23rd, 2014)
Stockholders Equity Note [Abstract] Statement [Table] Class of Stock [Axis] Class of Stock [Domain] Statement [Line Items] Stockholders Equity Note Disclosure [Text Block] STOCKHOLDER'S EQUITY Disclosure Outstanding Warrants To Purchase Shares Of Common Stock [Abstract] Disclosure - Outstanding Warrants to Purchase Shares of Common Stock [Abstract] Equity Components [Axis] Equity Component [Domain] Stockholders Equity Note Warrants, Convertible Notes Payable and Stock Options [Text Block] STOCK OPTIONS AND WARRANTS The entire disclosure relating to warrants issued under the Series A-2 Preferred Stock offering expired at the close of the merger. Stock option plans approved by board of directors, total number of shares authorized for issuance under each plan, effects of the Reverse Stock Split at the consummation of t
Conor Medsystems – Compensation Information for Executive Officers (February 27th, 2006)
The table below provides information regarding the 2005 cash bonus awarded to, and the 2006 annual base salary of, each executive officer of Conor Medsystems, Inc.
Conor Medsystems – September 27, 2005 VIA HAND DELIVERY Frank Litvack, M.D. Conor Medsystems, Inc. (September 30th, 2005)
As we discussed, this letter (the Agreement) sets forth the new terms and conditions of your employment relationship with Conor Medsystems, Inc. (the Company). On September 27, 2005, these terms and conditions were approved by the Companys Compensation Committee (Committee) of the Board of Directors (Board). Except as expressly stated herein, this Agreement supersedes and replaces all previous agreements between you and the Company, including but not limited to the Engagement Letter dated January 1, 2002, your Contract Extension dated August 7, 2003 and your letter agreement dated March 4, 2005. As noted below, your current stock option grants are not affected by this Agreement. The terms contained in this Agreement will become effective as of the date that both you and the Company sign this Agreement (the Effective Date).
Conor Medsystems – Chief Executive Change of Control and Severance Agreement (September 30th, 2005)
This Chief Executive Officer Change of Control and Severance Agreement (the Agreement) is made and entered into as of September 27, 2005, by and between Conor Medsystems, Inc., a Delaware corporation (the Company), and Frank Litvack, M.D. (the Executive).
Conor Medsystems – January 19, 2005 Azin Parhizgar Dear Azin: (January 25th, 2005)
This amendment to your offer letter (Amendment) sets forth the severance benefits that Conor MedSystems, Inc. (the Company) is offering to you in connection with your continued employment with the Company.
Conor Medsystems – [Conor Letterhead] (December 10th, 2004)
In connection with the execution and delivery of that certain Underwriting Agreement, dated as of December , 2004, by and among you, as the Selling Stockholder, Conor Medsystems, Inc. (the Company) and the Underwriters named therein, a copy of which is attached as Exhibit A hereto (the Underwriting Agreement), the Company has agreed to provide you with the following indemnification rights: